Drug research – Page 2 – Stockmark.IT

AstraZeneca builds £450m vaccine center in Liverpool as boost for UK

Shares of Viking Therapeutics more than doubled on’statistically important’ weight loss trial results

AstraZeneca unveils successes in treatment of lung cancer

Eli Lilly to launch weight loss drug in UK ‘within a few weeks’

Data shows that expired Pfizer Covid antiviral medications will cost Europe $2.2bn.

Syntara’s $10M Raise: Fueling Drug Development

AstraZeneca acquires US vaccine company for $1.1bn

Weight loss drug manufacturer plots a ‘buy Now, Pay Later’ offer

AstraZeneca defends its Covid-19 injection against accusations that it was defective

AstraZeneca signs a deal for an oral obesity drug that boosts profit forecasts

Early drug treatment for Alzheimer’s disease is beneficial according to new studies

AstraZeneca praises “clinically meaningful” cancer drug trial results

Merck opens a £1bn London research center with a plea for government support to industry

GSK signs £2.5bn deal with China Zhifei for shingles vaccine

Moderna reports success in trials for the dual Covid and influenza vaccine

Research links Covid antiviral to mutations that are ‘transmissible,’ according to the findings

UK invests overseas to fight antimicrobial resistance

Already, the Ozempic-killers are generating fat profits